Icon

TURALIO (nda211810)- (EQ 200MG BASE,EQ 125MG BASE)

PEXIDARTINIB HYDROCHLORIDE DAIICHI SANKYO INC
EQ 200MG BASE,EQ 125MG BASE
No No
2038-Jul-24 2024-Aug-02
None None
None No
TURALIO is a kinase inhibitor indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 200MG BASE ** ** - - -
EQ 125MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.